학술논문
Tumor levels of the mediators of ErbB2-driven anoikis resistance correlate with breast cancer relapse in patients receiving trastuzumab-based therapies
Document Type
Article
Author
Source
In: Breast Cancer Research and Treatment . (Breast Cancer Research and Treatment, June 2021, 187(3):743-758)
Subject
Language
English
ISSN
15737217
01676806
01676806